Consortium partners

The Consortium was established in July 2012 by Merck, Astellas Pharma Inc. (Astellas), Swiss Tropical and Public Health Institute (Swiss TPH) and Lygature. The Consortium operates through an innovative approach that engages new partners as needed:

  • at the beginning of 2014, Farmanguinhos and Simcyp, a Certara company, joined the Consortium as full partners (Simcyp retired in 2017)
  • in the summer of 2016, the SCI Foundation (SCI; until 2019 part of Imperial College London), joined 
  • at the beginning of 2018, Kenya Medical Research Institute (KEMRI) and Université Félix Houphouët-Boigny (UFHB) became full partners

Together, the partners bring many different areas of expertise to the project:

Current partners

Retired partners